Additionally, RBM38 has been shown to participate in the progression of breast cancer (49), acute myeloid leukemia (50), colorectal cancer, and renal cell carcinoma (51), via transcriptionally regulating many downstream targets in different ways (51). The gene discussed is RBM38; the disease is breast carcinoma.